4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-036466
Chief Commercial Officer acquired 34,947 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baldry Mark Chief Commercial Officer | 2023-10-31 | Grant or award | +34,947 | 34,947 | D |
Loading xslF345X05/wk-form4_1698958841.xml…